Amphotericin B Injectable, Liposomal
Product Images NDC 62756-954

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amphotericin B (NDC 62756-954). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-ampho-lipo-structure (Spl Ampho Lipo Structure)

An illustrated cross-sectional view of a liposome depicting the phospholipid bilayer structure with embedded amphotericin B molecules. Labels identify the 'phospholipid bilayer' forming the liposome's membrane and the 'amphotericin B molecules' contained within. This diagram visually explains the liposomal formulation of amphotericin B.*

FDA Label Image

Spl-amphotercin-structure (Spl Amphotercin Structure)

Chemical structure of Amphotericin B, showing its complex molecular arrangement including multiple hydroxyl groups, a macrolide ring, and a sugar moiety attached, consistent with the antifungal agent Amphotericin B.*

FDA Label Image

Spl-carton-label (Spl Carton Label)

Packaging label for Amphotericin B Liposome for Injection, 50 mg per vial, an intravenous injectable liposomal formulation. The label shows a single-dose vial with prescribing information included, distributed by Sun Pharmaceutical Industries, Inc. The label notes the product is sterile, nonpyrogenic, preservative-free, and highlights that the liposome form is not interchangeable with other Amphotericin B products on a mg per mg basis. Storage instructions specify 20° to 25°C with permitted excursions.*

FDA Label Image

Spl-figure1 (Spl Figure1)

A line graph showing the mean change in creatinine levels (mg/dL) over 4 weeks on study for two treatment groups: Amphotericin B Liposome for Injection at 3 mg/kg/day and Amphotericin B at 0.6 mg/kg/day. The graph includes sample sizes for each time point and compares renal function changes between the two dosing regimens.*

FDA Label Image

Spl-figure2 (Spl Figure2)

A line graph showing mean creatinine concentration (mg/dL) over days of test comparing two groups: patients with pretreatment values greater than 1.7 mg/dL and all episodes. The graph plots creatinine levels on the vertical axis against the test days on the horizontal axis, with the former group represented by a blue line with diamond markers and the latter by a pink line with square markers.*

FDA Label Image

Spl-vial-label (Spl Vial Label)

Label for Amphotericin B Liposome for Injection, 50 mg per vial, injectable liposomal dosage form for intravenous use. The label includes active ingredient details, storage instructions (20° to 25°C), and manufacturer information (Sun Pharmaceutical Industries, Inc. and Sun Pharmaceutical Medicare Limited in India). It states the product is sterile, nonpyrogenic, preservative-free, single-dose vial, and mentions reconstitution requirements for intravenous infusion only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.